Skip to main content
logo
Vista Pharmaceuticals Limited (BOM:524711)
India flag India · Delayed Price · Currency is INR
7.00
-0.12 (-1.69%)
At close: Jul 28, 2026

Vista Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
86.3100.75102.8810.043.9512.66
Revenue Growth
-13.51%-2.07%924.99%154.42%-68.85%-94.44%
Gross Profit
5.2515.4110.02-18.570.054.2
Operating Income
-90.78-46.31-39.05-45.01-18.27-24.57
Net Income
-76.94-46.49-45.12-56.62-8.89-20.09
Earnings Per Share
-1.32-0.79-1.03-1.54-0.24-0.58
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
1.337.330.942.040.721.4
Total Debt
85.0274.0479.6599.59125.51107.12
Net Cash (Debt)
-83.69-66.71-78.7-97.55-124.79-105.72
Net Cash Growth
------
Net Cash Per Share
-1.43-1.13-1.80-2.65-3.39-3.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
--69.85-49.14-17.11-9.93-67.47
Capital Expenditures
--4.4-7.9-12.7-0.14-2.99
Free Cash Flow
--74.25-57.04-29.82-10.07-70.46
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
6.08%15.29%9.74%-185.00%1.22%33.14%
Operating Margin
-105.19%-45.97%-37.96%-448.47%-463.07%-194.04%
Pretax Margin
-109.44%-52.51%-50.33%-585.46%-663.52%-300.96%
Profit Margin
-89.16%-46.14%-43.86%-564.11%-225.25%-158.62%
FCF Margin
--73.70%-55.44%-297.07%-255.34%-556.35%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
PS Ratio
4.998.196.8631.0885.9931.87